GNA11 and colorectal cancer: GNA* (GNAS, GNAQ, or GNA11) aberrations in gastrointestinal excluding appendiceal and colorectal cancer account for 7.3% in all GNA* mutated tumors, and there is a trend toward lower median overall survival in patients with GNA* mutated tumors compared with GNA* wild-type tumors (38).